GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » Cash-to-Debt

SGRY (Surgery Partners) Cash-to-Debt : 0.06 (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Surgery Partners's cash to debt ratio for the quarter that ended in Jun. 2024 was 0.06.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Surgery Partners couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2024.

The historical rank and industry rank for Surgery Partners's Cash-to-Debt or its related term are showing as below:

SGRY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03   Med: 0.06   Max: 0.17
Current: 0.06

During the past 12 years, Surgery Partners's highest Cash to Debt Ratio was 0.17. The lowest was 0.03. And the median was 0.06.

SGRY's Cash-to-Debt is ranked worse than
88.29% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 0.765 vs SGRY: 0.06

Surgery Partners Cash-to-Debt Historical Data

The historical data trend for Surgery Partners's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Surgery Partners Cash-to-Debt Chart

Surgery Partners Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.10 0.12 0.10 0.06

Surgery Partners Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.08 0.06 0.06 0.06

Competitive Comparison of Surgery Partners's Cash-to-Debt

For the Medical Care Facilities subindustry, Surgery Partners's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgery Partners's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Surgery Partners's Cash-to-Debt falls into.



Surgery Partners Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Surgery Partners's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Surgery Partners's Cash to Debt Ratio for the quarter that ended in Jun. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgery Partners  (NAS:SGRY) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Surgery Partners Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Surgery Partners's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgery Partners Business Description

Traded in Other Exchanges
Address
340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Executives
Harrison R. Bane officer: American Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Danielle Burkhalter officer: Chief Human Resources Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Bradley R. Owens officer: National Group President 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
David T Doherty officer: Chief Financial Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Jason Eric Evans officer: EVP & Chief Operating Officer 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo officer: President, Atlantic Group 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock officer: Sr. VP, Gen Couns. & Sec. 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham officer: Chief Strategy Officer 310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Bain Capital Investors Llc director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
T. Devin O'reilly director, 10 percent owner C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix director, 10 percent owner
Andrew T. Kaplan director C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt director, officer: Chief Executive Officer 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Bain Capital Partners Xi, L.p. director, 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Xi, L.p. director, 10 percent owner JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116